TRCT
QGENF

Tower Research Capital (TRC)’s QIAGEN NV QGENF Stock Holding History

Tower Research Capital (TRC)’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-318
Closed -$7K – 5351
2016
Q2 		$7K Sell
318
-4,598
-94% -$101K ﹤0.01% 3234
2016
Q1 		$110K Buy
+4,916
New +$110K 0.02% 474
2015
Q3 		– Sell
-3,981
Closed -$99K – 5721
2015
Q2 		$99K Sell
3,981
-13,290
-77% -$330K 0.01% 847
2015
Q1 		$435K Buy
17,271
+14,355
+492% +$362K 0.05% 194
2014
Q4 		$68K Buy
2,916
+2,583
+776% +$60.2K 0.01% 887
2014
Q3 		$8K Sell
333
-17,531
-98% -$421K ﹤0.01% 3051
2014
Q2 		$437K Buy
17,864
+13,415
+302% +$328K 0.06% 310
2014
Q1 		$94K Buy
4,449
+294
+7% +$6.21K 0.01% 747
2013
Q4 		$99K Buy
4,155
+1,862
+81% +$44.4K 0.02% 878
2013
Q3 		$49K Buy
2,293
+26
+1% +$556 0.01% 1944
2013
Q2 		$45K Buy
+2,267
New +$45K ﹤0.01% 1035

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Tower Research Capital (TRC)'s QGENF Position: Q3 2016 in Review

Tower Research Capital (TRC) sold out of QIAGEN NV (QGENF) in Q3 2016, closing a stake of 318 shares — an estimated $7K sold.

Tower Research Capital (TRC) first reported a position in QGENF in Q2 2013 and held it in 11 quarters. The position peaked at $437K in Q2 2014. 210 funds tracked by Wall St. Rank hold QGENF as of Q3 2016.

  • Tower Research Capital (TRC) reported no remaining QIAGEN NV position as of Q3 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 318 QIAGEN NV shares in Q3 2016, an estimated $7K.
  • Tower Research Capital (TRC) first reported a position in QIAGEN NV in Q2 2013 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s QIAGEN NV position peaked at $437K in Q2 2014.
  • 210 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.